https://orcid.org/0000-0001-9559-3846
References
- Gunaydin DB. Weight and height adjusted dose regimen or fixed ED95 dose of intrathecal hyperbaric bupivacaine for cesarean delivery in parturients with different BMIs: which would be optimal? Curr Med Res Opin. 2022. DOI: 10.1080/03007995.2022.2131301
- Ituk US, Ha N, Ravindranath S, et al. The association of maternal obesity with fetal pH in parturients undergoing cesarean delivery under spinal anesthesia. Curr Med Res Opin. 2022;38(8):1467–1472.
- Lee Y, Balki M, Parkes R, et al. Dose requirement of intrathecal bupivacaine for cesarean delivery is similar in obese and normal weight women. Rev Bras Anestesiol. 2009;59(6):674–683.
- Carvalho B, Collins J, Drover DR, et al. ED(50) and ED(95) of intrathecal bupivacaine in morbidly obese patients undergoing cesarean delivery. Anesthesiology. 2011;114(3):529–535.
- Harten JM, Boyne I, Hannah P, et al. Effects of a height and weight adjusted dose of local anaesthetic for spinal anaesthesia for elective Caesarean section. Anaesthesia. 2005;60(4):348–353.
- Palmer CM, Emerson S, Volgoropolous D, et al. Dose-response relationship of intrathecal morphine for postcesarean analgesia. Anesthesiology. 1999;90(2):437–444.
- Girgin NK, Gurbet A, Turker G, et al. Intrathecal morphine in anesthesia for cesarean delivery: dose-response relationship for combinations of low-dose intrathecal morphine and spinal bupivacaine. J Clin Anesth. 2008;20(3):180–185.
- Milner AR, Bogod DG, Harwood RJ. Intrathecal administration of morphine for elective Caesarean section. A comparison between 0.1 mg and 0.2 mg. Anaesthesia. 1996;51(9):871–873.